股市新闻
最新财经新闻 · 更新于 五月 24, 2026
Delve 被指控以“虚假合规”误导客户
Delve accused of misleading customers with ‘fake compliance’
The panel consensus is that Delve's alleged 'structural fraud' poses an existential risk, with potential regulatory scrutiny, customer churn, and …
2026年美国最佳退休州
The Best Retirement States in the U.S. in 2026
The panel consensus is bearish on the Motley Fool's ranking of best states for retirement. Key concerns include the high …
参议院将周末工作，辩论《拯救美国法案》
Senate To Work Through Weekend Debating SAVE America Act
The panel generally agrees that the SAVE America Act is unlikely to pass due to lack of votes, but there's …
西部退休？ 这些城市让梦想比你想象的更实惠。
Retiring Out West? These Cities Make the Dream More Affordable Than You'd Think
While the discussed cities offer affordable housing, the panel consensus is that they present significant risks for retirees, including high …
吉姆·克莱默表示“我们并未为慈善信托买入戴尔”
Jim Cramer Says “We Didn’t Catch Dell for the Charitable Trust”
The panel has mixed views on Dell (DELL), with concerns about margin compression, high debt levels, and dependence on a …
Cramer谈GE Vernova：“它拥有最好的业务组合”
Jim Cramer on GE Vernova: “It’s Just Got the Best Book of Business”
GE Vernova (GEV) is benefiting from rising data center load and electrification, but its high valuation and execution risks, particularly …
Jim Cramer 谈 ImmunityBio：“该股票属于‘魔法思维’时代”
Jim Cramer on ImmunityBio: “That Stock Is Part of the Magical Thinking Era”
The panel consensus is bearish on ImmunityBio (IBRX), citing high volatility, execution risk in commercial launch, potential dilution, and unverified …
Jim Cramer 称 NuScale Power (SMR) 的股票在有意义的成果出来前还需要数年时间，股价下跌
NuScale Power’s (SMR) Shares Down After Jim Cramer Said It’d Be Years Before Anything Meaningful Came Out
The panel consensus is that NuScale (SMR) faces significant challenges, including a high cash burn rate, long commercialization timelines, and …
Jim Cramer 称 Dollar Tree 财报“稳健”，但“指引略显令人失望”
Jim Cramer Calls Dollar Tree’s Earnings “Solid” But “Somewhat Disappointing Guidance”
The panel is bearish on DLTR due to structural margin compression, potential tariff reinstatement, and execution issues with the Family …
吉姆·克莱默谈 Five Below：“我认为它还有上涨空间”
Jim Cramer on Five Below: “I Think It’s Got More Room to Run”
The panel is divided on Five Below's (FIVE) recent performance and future prospects. While some see a sustainable turnaround driven …
吉姆·克雷默谈 Reddit：“我认为这是一项非常有价值的资产”
Jim Cramer on Reddit: “I Think It’s an Incredibly Valuable Property”
The panel's net takeaway is that Reddit's valuation is stretched given its unproven monetization and reliance on volunteer labor. While …
吉姆·克雷默谈强生公司：“这是一只教科书式的放缓股票”
Jim Cramer on Johnson & Johnson: “It’s a Textbook Slowdown Stock”
The panel generally agrees that the FDA approval of ICOTYDE is positive but incremental for Johnson & Johnson (JNJ). The …